Skip to main content
Vera Therapeutics, Inc. logo

Vera Therapeutics, Inc. — Investor Relations & Filings

Ticker · VERA ISIN · US92337R1014 US Professional, scientific and technical activities
Filings indexed 418 across all filing types
Latest filing 2022-02-18 Director's Dealing
Country US United States of America
Listing US VERA

About Vera Therapeutics, Inc.

https://veratx.com/

Vera Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological and rare diseases. The company's mission is to change the standard of care and improve patients' lives. Its lead product candidate is atacicept, a novel biologic molecule being developed for the treatment of IgA nephropathy (IgAN), a progressive autoimmune kidney disease. Vera Therapeutics aims to advance its pipeline of innovative therapies to address significant unmet medical needs within immunology.

Recent filings

Filing Released Lang Actions
FORM 4 SUBMISSION
Director's Dealing
2022-02-18 English
FORM 4 SUBMISSION
Director's Dealing
2022-02-18 English
FORM 4
Director's Dealing
2022-02-15 English
VERA THERAPEUTICS, INC.
Major Shareholding Notification
2022-02-14 English
424B4
Capital/Financing Update Classification · 100% confidence The document is a detailed prospectus filed pursuant to Rule 424(b)(4) related to a public offering of Class A common stock by Vera Therapeutics, Inc. It includes extensive information about the offering, underwriting, risk factors, financial data, management discussion and analysis, business overview, and other disclosures typical of a securities offering prospectus. The document is not an annual report, earnings release, or any other financial report type but rather a capital raising document. The presence of underwriting details, offering price, shares offered, and use of proceeds confirms this is a capital/financing update document. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2022-02-11 English
SCHEDULE 13G
Major Shareholding Notification
2022-02-11 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.